SCHEMBL1219449

SCHEMBL1219449

CC(C)(C)C(=Cc1ccc(Cl)cc1Cl)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 1/20 0.47
GABRG2 P18507 1/20 0.47
GABRB3 P28472 1/20 0.47
TDP1 Q9NUW8 1/20 0.46
MAPT P10636 4/20 0.42
ALDH1A1 P00352 4/20 0.42
SMN1; SMN2 Q16637 4/20 0.42
RAB9A P51151 3/20 0.42
NPC1 O15118 1/20 0.42
POLB P06746 1/20 0.42
GAA P10253 3/20 0.42
KDM4E B2RXH2 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
ACHE P22303 1/20 0.41
TSHR P16473 1/20 0.41
CASP1 P29466 1/20 0.41
JAK2 O60674 1/20 0.40
TP53 P04637 2/20 0.40
PDK1 Q15118 1/20 0.39
PDK2 Q15119 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16738482 0.81 HPGD (0.36) RAB9ANPC1TSHRHPGD
SCHEMBL16738523 0.79 ALDH1A1 (0.35) TDP1ALDH1A1RAB9ANPC1POLB
SCHEMBL7822855 0.78 GABRA1 (0.56) GABRA1GABRG2GABRB3TDP1MAPT
SCHEMBL7822858 0.78 GABRA1 (0.56) GABRA1GABRG2GABRB3TDP1MAPT
SCHEMBL5597364 0.78 TDP1 (0.53) GABRA1GABRG2GABRB3TDP1MAPT
SCHEMBL10627669 0.76 GABRA1 (0.57) GABRA1GABRG2GABRB3TDP1MAPT
SCHEMBL10627662 0.76 GABRA1 (0.57) GABRA1GABRG2GABRB3TDP1MAPT
SCHEMBL1407820 0.75 GABRA1 (0.53) GABRA1GABRG2GABRB3TDP1MAPT
SCHEMBL1407819 0.75 GABRA1 (0.53) GABRA1GABRG2GABRB3TDP1MAPT
SCHEMBL1284639 0.72 MAPT (0.58) TDP1MAPTALDH1A1SMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7893096-B2 For example, N-methyl-4-[(2-{[2-(1-methylethyl)phenyl]amino}-1 H-benzimidazol-5-yl)oxy]pyridine-2-carboxamide; administering the compounds alone or in combination with another agent for the treatment of cancer, infectious diseases and/or allergies/asthma NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US) 2011-02-22 US disclosed